Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

LivaNova PLC

LIVN
Current price
39.24 USD +0.46 USD (+1.19%)
Last closed 38.56 USD
ISIN GB00BYMT0J19
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 2 723 185 152 USD
Yield for 12 month -22.45 %
1Y
3Y
5Y
10Y
15Y
LIVN
21.11.2021 - 28.11.2021

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom. Address: 20 Eastbourne Terrace, London, United Kingdom, W2 6LG

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

69.00 USD

P/E ratio

116.63

Dividend Yield

Current Year

+1 153 545 000 USD

Last Year

+1 021 800 000 USD

Current Quarter

+318 120 000 USD

Last Quarter

+318 575 000 USD

Current Year

+771 250 000 USD

Last Year

+707 200 000 USD

Current Quarter

+225 264 000 USD

Last Quarter

+220 365 000 USD

Key Figures LIVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 212 630 000 USD
Operating Margin TTM 14.09 %
Price to Earnings 116.63
Return On Assets TTM 4.34 %
PEG Ratio 0.47
Return On Equity TTM 1.87 %
Wall Street Target Price 69.00 USD
Revenue TTM 1 241 739 008 USD
Book Value 24.13 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 11.20 %
Dividend Yield
Gross Profit TTM 696 728 000 USD
Earnings per share 0.43 USD
Diluted Eps TTM 0.43 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 1 400.00 %
Profit Margin 1.91 %

Dividend Analytics LIVN

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History LIVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation LIVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 116.63
Forward PE 20.96
Enterprise Value Revenue 2.46
Price Sales TTM 2.19
Enterprise Value EBITDA 55.68
Price Book MRQ 2.08

Financials LIVN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators LIVN

For 52 weeks

43.15 USD 64.48 USD
50 Day MA 52.00 USD
Shares Short Prior Month 2 362 499
200 Day MA 52.98 USD
Short Ratio 4.18
Shares Short 2 313 754
Short Percent 5.65 %